Hamilton Thorne Ltd. (HTLZF)
USD 1.59
(N/A%)
USD 1.59
(N/A%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 68.45 Million USD | 22.53% |
| 2022 | 55.87 Million USD | 6.72% |
| 2021 | 52.35 Million USD | 31.61% |
| 2020 | 39.77 Million USD | 12.5% |
| 2019 | 35.35 Million USD | 21.03% |
| 2018 | 29.21 Million USD | 32.06% |
| 2017 | 22.12 Million USD | 110.38% |
| 2016 | 10.51 Million USD | 16.39% |
| 2015 | 9.03 Million USD | 3.75% |
| 2014 | 8.7 Million USD | 16.45% |
| 2013 | 7.47 Million USD | 18.2% |
| 2012 | 6.32 Million USD | -11.64% |
| 2011 | 7.15 Million USD | 15.46% |
| 2010 | 6.2 Million USD | 29.32% |
| 2009 | 4.79 Million USD | 19285.03% |
| 2008 | 24.73 Thousand USD | -27.33% |
| 2007 | 34.03 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 19.3 Million USD | 1.86% |
| 2024 Q2 | 19.07 Million USD | -1.16% |
| 2023 FY | 68.45 Million USD | 22.53% |
| 2023 Q2 | 16.43 Million USD | -1.52% |
| 2023 Q3 | 15.65 Million USD | -4.75% |
| 2023 Q4 | 18.95 Million USD | 21.06% |
| 2023 Q1 | 16.69 Million USD | 1.44% |
| 2022 Q4 | 16.45 Million USD | 22.2% |
| 2022 Q3 | 13.46 Million USD | -5.41% |
| 2022 FY | 55.87 Million USD | 6.72% |
| 2022 Q1 | 14.05 Million USD | -10.05% |
| 2022 Q2 | 14.23 Million USD | 1.3% |
| 2021 Q2 | 12.52 Million USD | 8.75% |
| 2021 Q1 | 11.51 Million USD | -6.02% |
| 2021 Q4 | 15.62 Million USD | 23.15% |
| 2021 FY | 52.35 Million USD | 31.61% |
| 2021 Q3 | 12.68 Million USD | 1.26% |
| 2020 Q3 | 9.79 Million USD | 33.56% |
| 2020 FY | 39.77 Million USD | 12.5% |
| 2020 Q2 | 7.33 Million USD | -29.46% |
| 2020 Q4 | 12.25 Million USD | 25.15% |
| 2020 Q1 | 10.39 Million USD | -4.11% |
| 2019 Q4 | 10.84 Million USD | 22.22% |
| 2019 Q1 | 7.63 Million USD | -5.38% |
| 2019 FY | 35.35 Million USD | 21.03% |
| 2019 Q2 | 8 Million USD | 4.86% |
| 2019 Q3 | 8.87 Million USD | 10.75% |
| 2018 Q1 | 7 Million USD | -2.48% |
| 2018 FY | 29.21 Million USD | 32.06% |
| 2018 Q4 | 8.07 Million USD | 18.14% |
| 2018 Q3 | 6.83 Million USD | -6.45% |
| 2018 Q2 | 7.3 Million USD | 4.31% |
| 2017 Q2 | 5.6 Million USD | 70.55% |
| 2017 Q1 | 3.28 Million USD | -9.97% |
| 2017 FY | 22.12 Million USD | 110.38% |
| 2017 Q4 | 7.18 Million USD | 18.64% |
| 2017 Q3 | 6.05 Million USD | 8.03% |
| 2016 Q4 | 3.64 Million USD | 49.05% |
| 2016 Q2 | 2.38 Million USD | 17.64% |
| 2016 FY | 10.51 Million USD | 16.39% |
| 2016 Q3 | 2.44 Million USD | 2.52% |
| 2016 Q1 | 2.02 Million USD | -22.72% |
| 2015 FY | 9.03 Million USD | 3.75% |
| 2015 Q4 | 2.62 Million USD | 26.62% |
| 2015 Q3 | 2.07 Million USD | -7.17% |
| 2015 Q2 | 2.23 Million USD | 6.52% |
| 2015 Q1 | 2.09 Million USD | -16.69% |
| 2014 Q1 | 1.96 Million USD | -13.46% |
| 2014 Q2 | 2.21 Million USD | 12.68% |
| 2014 Q3 | 2 Million USD | -9.25% |
| 2014 Q4 | 2.51 Million USD | 25.31% |
| 2014 FY | 8.7 Million USD | 16.45% |
| 2013 Q1 | 1.74 Million USD | -15.65% |
| 2013 Q2 | 1.82 Million USD | 4.94% |
| 2013 Q3 | 1.63 Million USD | -10.37% |
| 2013 Q4 | 2.27 Million USD | 38.65% |
| 2013 FY | 7.47 Million USD | 18.2% |
| 2012 Q4 | 2.06 Million USD | 42.02% |
| 2012 FY | 6.32 Million USD | -11.64% |
| 2012 Q2 | 1.23 Million USD | -21.59% |
| 2012 Q1 | 1.57 Million USD | -22.16% |
| 2012 Q3 | 1.45 Million USD | 17.78% |
| 2011 FY | 7.15 Million USD | 15.46% |
| 2011 Q4 | 2.02 Million USD | 8.82% |
| 2011 Q2 | 1.83 Million USD | 26.83% |
| 2011 Q1 | 1.44 Million USD | -14.87% |
| 2011 Q3 | 1.85 Million USD | 1.37% |
| 2010 Q4 | 1.69 Million USD | -0.9% |
| 2010 FY | 6.2 Million USD | 29.32% |
| 2010 Q2 | 1.6 Million USD | 36.24% |
| 2010 Q3 | 1.71 Million USD | 6.52% |
| 2010 Q1 | 1.18 Million USD | -1.38% |
| 2009 Q2 | 1.01 Million USD | 186461.04% |
| 2009 FY | 4.79 Million USD | 19285.03% |
| 2009 Q4 | 1.19 Million USD | -18.18% |
| 2009 Q3 | 1.46 Million USD | 43.6% |
| 2009 Q1 | 546.13 USD | -76.64% |
| 2008 FY | 24.73 Thousand USD | -27.33% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q1 | 10.95 Thousand USD | -42.96% |
| 2008 Q3 | 5609.21 USD | 0.0% |
| 2008 Q4 | 2337.85 USD | -58.32% |
| 2007 FY | 34.03 Thousand USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | 12.96 Thousand USD | 0.0% |
| 2007 Q4 | 19.19 Thousand USD | 48.13% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 714.7 Thousand USD | -9478.501% |
| IR-Med Inc. | - USD | -Infinity% |
| Polarean Imaging plc | 890.93 Thousand USD | -7583.89% |
| Medical Supply International USA, Inc. | 2.81 Million USD | -2329.852% |
| Avitar, Inc. | 3.1 Million USD | -2103.902% |
| AVITA Medical, Inc. | 50.56 Million USD | -35.397% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 91.287% |
| Zecotek Photonics Inc. | 86.61 Thousand USD | -78942.04% |
| QHSLab, Inc. | 1.4 Million USD | -4758.662% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 785.68 Million USD | 91.287% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 52.61 Million USD | -30.122% |
| Escalon Medical Corp. | 11.98 Million USD | -471.366% |
| Aurora Spine Corporation | 14.52 Million USD | -371.462% |
| BrainsWay Ltd. | 31.78 Million USD | -115.379% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 257.39 Thousand USD | -26496.184% |
| Vivos Inc. | 19.5 Thousand USD | -350968.262% |
| MicroPort Scientific Corporation | 950.72 Million USD | 92.799% |
| Kelyniam Global, Inc. | 2.67 Million USD | -2461.72% |
| REMSleep Holdings, Inc. | 203.71 Thousand USD | -33504.449% |
| CYduct Diagnostics, Inc. | 84.48 Thousand USD | -80931.096% |
| Nanomix Corporation | 15.45 Thousand USD | -442995.864% |
| Theraclion SA | 1.82 Million USD | -3656.861% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 661.55 Thousand USD | -10248.169% |
| Positron Corporation | 734.66 Thousand USD | -9218.29% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.34 Million USD | -4975.467% |
| Lombard Medical, Inc. | 12.16 Million USD | -462.563% |
| ALR Technologies Inc. | 7468.00 USD | -916588.685% |
| Stratec SE | 289.14 Million USD | 76.324% |
| Vycor Medical, Inc. | 1.46 Million USD | -4586.986% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Perimeter Medical Imaging AI, Inc. | 403.53 Thousand USD | -16864.737% |
| SANUWAVE Health, Inc. | 20.39 Million USD | -235.613% |
| VMS Rehab Systems, Inc. | 71.70 USD | -95478715.9% |
| Guided Therapeutics, Inc. | 98 Thousand USD | -69755.419% |
| Ingen Technologies, Inc. | 720.67 Thousand USD | -9399.154% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 2.84 Million USD | -2306.044% |
| Urologix, Inc. | 14.23 Million USD | -380.915% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 3.3 Million USD | -1972.751% |
| SS Innovations International, Inc. | 5.87 Million USD | -1064.314% |
| Qualis Innovations, Inc. | 40.17 Thousand USD | -170300.276% |
| Smith & Nephew plc | 5.68 Billion USD | 98.795% |
| NIOX Group Plc | 46.84 Million USD | -46.134% |
| Fuse Medical, Inc. | 16.11 Million USD | -324.798% |
| Broncus Holding Corporation | 10.25 Million USD | -567.56% |
| Brain Scientific Inc. | 214.56 Thousand USD | -31805.777% |
| Pressure BioSciences, Inc. | 1.97 Million USD | -3361.401% |
| Health Logic Interactive Inc. | - USD | -Infinity% |